The new drug, developed in the Cochrane lab, helps pre-term infants breathe.
“As the campus continues to expand as a center of scientific excellence, Dawn [Johnson] brings her experience as a scientist, knowledge of the federal funding process for research, and talents as a manager to Scripps Florida,” says Scripps Research President Michael A. Marletta.
The findings from the Luo lab point to a potentially effective new therapeutic target for cancer treatment and prevention.
The project, led by cancer biologist John Cleveland and chemist William Roush, will focus on inhibiting a hallmark of cancer cell metabolism.